Legend Biotech Announces FDA Approval of CARVYKTI Gallery Legend Biotech Announces FDA Approval of CARVYKTI 全部新闻, 美国投资项目 Legend Biotech Announces FDA Approval of CARVYKTIartrix2022-03-10T23:03:17-08:002月 28th, 2022|阅读更多
Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering Gallery Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering 全部新闻, 美国投资项目 Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offeringartrix2022-03-11T09:34:54-08:002月 22nd, 2022|阅读更多
Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals Gallery Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals 全部新闻, 美国投资项目 Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticalsartrix2021-12-15T21:57:06-08:0012月 8th, 2021|阅读更多
Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market Gallery Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market 全部新闻, 美国投资项目 Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market artrix2022-03-10T23:01:42-08:0011月 30th, 2021|阅读更多
Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) 全部新闻, 美国投资项目 Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)artrix2022-03-10T22:59:36-08:0011月 23rd, 2021|阅读更多
IO Biotech, Inc. Announces Pricing of Initial Public Offering Gallery IO Biotech, Inc. Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 IO Biotech, Inc. Announces Pricing of Initial Public Offeringartrix2022-03-10T22:57:02-08:0011月 5th, 2021|阅读更多
PatientPop and Kareo Merge to Create All-In-One Provider Platform Gallery PatientPop and Kareo Merge to Create All-In-One Provider Platform 全部新闻, 美国投资项目 PatientPop and Kareo Merge to Create All-In-One Provider Platformartrix2022-03-10T22:55:58-08:0011月 2nd, 2021|阅读更多
Minerva Surgical Announces Pricing of Initial Public Offering Gallery Minerva Surgical Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Minerva Surgical Announces Pricing of Initial Public Offeringartrix2022-03-10T22:55:05-08:0010月 21st, 2021|阅读更多
Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Gallery Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering 全部新闻, 美国投资项目 Ventyx Biosciences Announces Pricing of Upsized Initial Public Offeringartrix2022-03-10T22:54:00-08:0010月 20th, 2021|阅读更多
HistoWiz Raises $32M Series A Financing Gallery HistoWiz Raises $32M Series A Financing 全部新闻, 美国投资项目 HistoWiz Raises $32M Series A Financingartrix2022-03-10T22:52:48-08:0010月 19th, 2021|阅读更多
Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency Gallery Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency 全部新闻, 美国投资项目 Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiencyartrix2022-03-10T22:48:50-08:008月 26th, 2021|阅读更多
Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® Gallery Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® 全部新闻, 美国投资项目 Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK®artrix2022-03-10T22:47:44-08:007月 16th, 2021|阅读更多
Sera Prognostics Announces Pricing of Initial Public Offering Gallery Sera Prognostics Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Sera Prognostics Announces Pricing of Initial Public Offeringartrix2022-03-10T22:46:20-08:007月 14th, 2021|阅读更多
Sinovac is Granted Emergency Use by the World Health Organization (WHO) Gallery Sinovac is Granted Emergency Use by the World Health Organization (WHO) 全部新闻, 美国投资项目 Sinovac is Granted Emergency Use by the World Health Organization (WHO)artrix2022-03-10T22:33:12-08:006月 1st, 2021|阅读更多
Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment Gallery Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment 全部新闻, 美国投资项目 Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatmentartrix2022-03-10T22:32:04-08:005月 28th, 2021|阅读更多
Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital Gallery Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital 全部新闻, 美国投资项目 Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capitalartrix2022-03-10T22:30:28-08:005月 26th, 2021|阅读更多
Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financing Gallery Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financing 全部新闻, 美国投资项目 Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financingartrix2022-03-10T22:29:08-08:005月 25th, 2021|阅读更多
Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreement Gallery Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreement 全部新闻, 美国投资项目 Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreementartrix2022-03-10T22:27:27-08:005月 17th, 2021|阅读更多
Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capital Gallery Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capital 全部新闻, 美国投资项目 Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capitalartrix2022-03-10T22:24:34-08:005月 6th, 2021|阅读更多
dMed Globaland Clinipace Merge to Accelerate Customer Success Gallery dMed Globaland Clinipace Merge to Accelerate Customer Success 全部新闻, 美国投资项目 dMed Globaland Clinipace Merge to Accelerate Customer Successartrix2022-03-11T09:32:55-08:004月 28th, 2021|阅读更多
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering Gallery Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering 全部新闻, 美国投资项目 Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offeringartrix2022-03-11T09:29:33-08:004月 22nd, 2021|阅读更多
Instil Bio Announces Pricing of Upsized Initial Public Offering Gallery Instil Bio Announces Pricing of Upsized Initial Public Offering 全部新闻, 美国投资项目 Instil Bio Announces Pricing of Upsized Initial Public Offeringartrix2022-03-11T09:28:16-08:003月 18th, 2021|阅读更多
Bolt Biotherapeutics Strikes a Major Upsized $230M IPO for Next-Gen Cancer Work Gallery Bolt Biotherapeutics Strikes a Major Upsized $230M IPO for Next-Gen Cancer Work 全部新闻, 美国投资项目 Bolt Biotherapeutics Strikes a Major Upsized $230M IPO for Next-Gen Cancer Workartrix2022-03-10T22:20:11-08:002月 5th, 2021|阅读更多
Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock Gallery Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock 全部新闻, 美国投资项目 Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stockartrix2022-03-11T09:26:46-08:002月 4th, 2021|阅读更多
Surgical Specialties is Acquired by Corza Health Gallery Surgical Specialties is Acquired by Corza Health 全部新闻, 美国投资项目 Surgical Specialties is Acquired by Corza Healthartrix2022-03-10T22:16:50-08:002月 1st, 2021|阅读更多
Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry. Gallery Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry. 全部新闻, 美国投资项目 Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry.artrix2022-03-10T22:12:04-08:001月 15th, 2021|阅读更多
Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China Gallery Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China 全部新闻, 美国投资项目 Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater Chinaartrix2022-03-10T22:09:47-08:001月 11th, 2021|阅读更多
Gracell Biotechnologies Announces Pricing of Initial Public Offering Gallery Gracell Biotechnologies Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Gracell Biotechnologies Announces Pricing of Initial Public Offeringartrix2022-03-11T09:22:31-08:001月 8th, 2021|阅读更多
Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription Gallery Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription 全部新闻, 美国投资项目 Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscriptionartrix2020-11-01T16:51:55-08:009月 17th, 2020|阅读更多
PatientPop Announces $50M in Series C Funding Gallery PatientPop Announces $50M in Series C Funding 全部新闻, 美国投资项目 PatientPop Announces $50M in Series C Fundingartrix2020-11-01T16:49:38-08:008月 25th, 2020|阅读更多
ALX Oncology Announces Pricing of Initial Public Offering Gallery ALX Oncology Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 ALX Oncology Announces Pricing of Initial Public Offeringartrix2020-07-25T10:53:00-07:007月 16th, 2020|阅读更多
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Gallery Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital 全部新闻, 美国投资项目 Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capitalartrix2020-07-16T22:37:02-07:007月 15th, 2020|阅读更多
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Gallery IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants 全部新闻, 美国投资项目 IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrantsartrix2020-06-20T10:49:33-07:006月 18th, 2020|阅读更多
Legend Biotech Corporation Announces Pricing of Public Offering Gallery Legend Biotech Corporation Announces Pricing of Public Offering 全部新闻, 美国投资项目 Legend Biotech Corporation Announces Pricing of Public Offeringartrix2022-03-11T09:31:11-08:006月 5th, 2020|阅读更多
Gilead to Acquire Forty Seven for $4.9 Billion Gallery Gilead to Acquire Forty Seven for $4.9 Billion 全部新闻, 美国投资项目 Gilead to Acquire Forty Seven for $4.9 Billionartrix2020-06-18T17:43:41-07:003月 2nd, 2020|阅读更多
Passage Bio Announces Pricing of Initial Public Offering Gallery Passage Bio Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Passage Bio Announces Pricing of Initial Public Offeringartrix2020-06-18T17:41:04-07:002月 27th, 2020|阅读更多
Revolution Medicines Announces Pricing of Initial Public Offering Gallery Revolution Medicines Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Revolution Medicines Announces Pricing of Initial Public Offeringartrix2020-06-18T17:42:30-07:002月 12th, 2020|阅读更多
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors Gallery Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors 全部新闻, 美国投资项目 Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumorsartrix2019-11-13T04:27:18-08:0011月 11th, 2019|阅读更多
Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants Gallery Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants 全部新闻, 美国投资项目 Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrantsartrix2020-06-20T10:53:23-07:0011月 7th, 2019|阅读更多
IGM Biosciences Announces Pricing of Initial Public Offering Gallery IGM Biosciences Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 IGM Biosciences Announces Pricing of Initial Public Offeringartrix2020-06-18T17:39:47-07:009月 17th, 2019|阅读更多
AtriCure签署收购SentreHEART的最终协议 Gallery AtriCure签署收购SentreHEART的最终协议 全部新闻, 美国投资项目 AtriCure签署收购SentreHEART的最终协议artrix2019-10-24T03:34:58-07:008月 12th, 2019|阅读更多
MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital Gallery MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital 全部新闻, 美国投资项目 MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capitalartrix2020-11-01T16:47:27-08:003月 4th, 2019|阅读更多
Menlo Therapeutics公司的II期临床研究成功证明司洛匹坦能够减少银屑病相关的瘙痒症 Gallery Menlo Therapeutics公司的II期临床研究成功证明司洛匹坦能够减少银屑病相关的瘙痒症 全部新闻, 美国投资项目 Menlo Therapeutics公司的II期临床研究成功证明司洛匹坦能够减少银屑病相关的瘙痒症artrix2019-10-24T03:38:14-07:0012月 10th, 2018|阅读更多
Impel NeuroPharma完成6750万美元的D轮融资 Gallery Impel NeuroPharma完成6750万美元的D轮融资 全部新闻, 美国投资项目, 维梧新闻 Impel NeuroPharma完成6750万美元的D轮融资artrix2019-10-24T03:25:40-07:0012月 6th, 2018|阅读更多
Biohaven公司发布了Rimegepant Zydis®口腔溶解片(ODT)III期临床试验积极结果:急性偏头痛的精准疗法,效果迅速、持久 Gallery Biohaven公司发布了Rimegepant Zydis®口腔溶解片(ODT)III期临床试验积极结果:急性偏头痛的精准疗法,效果迅速、持久 全部新闻, 美国投资项目 Biohaven公司发布了Rimegepant Zydis®口腔溶解片(ODT)III期临床试验积极结果:急性偏头痛的精准疗法,效果迅速、持久artrix2019-10-24T03:24:10-07:0012月 3rd, 2018|阅读更多
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China Gallery Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China 全部新闻, 美国投资项目, 维梧新闻 Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in Chinaartrix2019-10-24T03:22:56-07:0011月 8th, 2018|阅读更多
Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资,用于推进NASH和癌症药物的研发 Gallery Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资,用于推进NASH和癌症药物的研发 全部新闻, 美国投资项目, 维梧新闻 Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资,用于推进NASH和癌症药物的研发artrix2019-10-24T03:22:19-07:0010月 30th, 2018|阅读更多
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering Gallery Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Crinetics Pharmaceuticals Announces Pricing of Initial Public Offeringartrix2019-10-24T03:20:54-07:007月 17th, 2018|阅读更多
Tricida Announces Pricing of Initial Public Offering Gallery Tricida Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Tricida Announces Pricing of Initial Public Offeringartrix2019-10-24T03:39:35-07:006月 27th, 2018|阅读更多
Tricida Announces Pricing of Initial Public Offering Gallery Tricida Announces Pricing of Initial Public Offering 全部新闻, 美国投资项目 Tricida Announces Pricing of Initial Public Offeringartrix2019-10-24T03:19:55-07:006月 27th, 2018|阅读更多
Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant Expanded Access Program For Pitolisant Is Open And Patients Are Being Enrolled Gallery Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant Expanded Access Program For Pitolisant Is Open And Patients Are Being Enrolled 全部新闻, 美国投资项目 Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant Expanded Access Program For Pitolisant Is Open And Patients Are Being Enrolledartrix2019-10-24T03:18:10-07:005月 21st, 2018|阅读更多